Summarized by Masters of Longevity from PR Newswire.
This article previews a science news piece about using pulsed electromagnetic fields to shift immune cells’ behavior against breast tumours, explaining the approach and potential clinical development.
Key Takeaways
- Ten-minute pulsed electromagnetic field exposures activated TRPC1 channels to convert M2-like TAMs to an M1 anti-tumour state.
- PEMF treatment alone eradicated tumours in 75% of tested preclinical breast cancer models after four 30-minute sessions.
- The PEMF device used completed a Phase 1 safety trial and the team is seeking partners for Phase 2 efficacy trials.
